NYGC In the News: An Introduction to the New York Genome Center and a Look at Its Pioneering Work in ALS
The pioneering work of the Center for Genomics of Neurodegenerative Disease (CGND) at the New York Genome Center (NYGC) is profiled in a four-page article in the “Rare Neurological Disease Special Report” published by Neurology Reviews in March 2019.
In the profile, Hemali Phatnani, PhD, Director, CGND, discusses the CGND’s key goals: serving as a hub for collaboration, building tools and resources for the research community, and conducting key research initiatives, including current studies in cell-cell interactions using spatial transcriptomics.